EV/EBITDA:
-1.36+0.04(+2.86%)Summary
- As of today, NTLA EV/EBITDA is -1.36, with a rise of +0.04 (+2.86%) during the current trading session.
- Over the past year, NTLA EV/EBITDA has increased by +0.12 (+8.11%).
- NTLA EV/EBITDA is now -172.00% below its all-time high of -0.50.
Performance
NTLA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NTLA EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +2.9% | -2.7% | -1.7% |
| 1M1 Month | -9.7% | +9.9% | +5.8% |
| 3M3 Months | +29.9% | -35.8% | -27.7% |
| 6M6 Months | -18.3% | +3.0% | -6.4% |
| YTDYTD | +10.5% | -21.6% | -23.1% |
| 1Y1 Year | +8.1% | -19.9% | -31.7% |
| 5Y5 Years | +94.9% | -80.0% | -83.5% |
NTLA EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -1.13 | -20.4% | -1.56 | +12.8% |
| 3M | 3-Month | -1.13 | -20.4% | -6.15 | +77.9% |
| 6M | 6-Month | -1.07 | -27.1% | -6.15 | +77.9% |
| 1Y | 1-Year | -0.50 | -172.0% | -6.15 | +77.9% |
| 3Y | 3-Year | -0.50 | -172.0% | -7.77 | +82.5% |
| 5Y | 5-Year | -0.50 | -172.0% | -69.81 | +98.0% |
| All-Time | All-Time | -0.50 | -172.0% | -69.81 | +98.0% |
NTLA EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.36(+10.5%) |
| 2024 | -1.52(+62.3%) |
| 2023 | -4.03(+8.2%) |
| 2022 | -4.39(+85.9%) |
| 2021 | -31.16(-33.4%) |
| Date | Value |
|---|---|
| 2020 | -23.35(-395.8%) |
| 2019 | -4.71(-44.9%) |
| 2018 | -3.25(+54.4%) |
| 2017 | -7.12(-11.1%) |
| 2016 | -6.41 |
FAQ
- What is Intellia Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Intellia Therapeutics, Inc.?
- What is NTLA EV/EBITDA year-to-date change?
- What is Intellia Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Intellia Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of NTLA is -1.36
What is the all-time high EV/EBITDA for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high EV/EBITDA is -0.50
What is NTLA EV/EBITDA year-to-date change?
Intellia Therapeutics, Inc. EV/EBITDA has changed by +0.16 (+10.53%) since the beginning of the year
What is Intellia Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, NTLA EV/EBITDA has changed by +0.12 (+8.11%)